Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

More than half a million Brits are thought to be now relying on weight loss drugs like Ozempic and Mounjaro, amid a steady ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

Weight loss also becomes harder as we age; menopause, busy lifestyles and years of yo-yo dieting take their toll, and I've ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

Growing At-Home Men's Health Program in North America-PeterMD's Telemedicine Clinic Offers Transparent, Doctor-Supervised TRT ...